Colossal Biosciences

Colossal Biosciences Adds Renowned Ancient DNA Expert as Chief Science Officer

by | Mar 19, 2024
Dallas-based Colossal said that in her new role, MacArthur Award winner Beth Shapiro will oversee continued expansion of the company's de-extinction and conservation science teams. The company previously announced plans to "de-extinct" the woolly mammoth, the Tasmanian tiger, and the dodo bird.
MORE
D CEO and Dallas Innovates revealed the winners of the 2024 Innovation Awards at an event on January 24, 2023 held at On the Levee in the Design District.
Meet the Winners:
D CEO, Dallas Innovates Honor Top Innovators at 2024 Awards
At the annual Innovation Awards event, Dallas Innovates and D CEO revealed the winners in 17 categories and recognized all 74 North Texas finalists.
MORE
Decoding the Attraction: Why These Business Leaders and Entrepreneurs Make Dallas-Fort Worth Home
Nextdoor.com co-founder and recent Dallas-Fort Worth transplant Nirav Tolia puts it simply: “It’s a great place to live.” Here's why Tolia and other dynamic newcomers believe the fast-growing region is a land of opportunity and community for 21st-century pioneers.
MORE

Here Be Dragons: Colossal Partners with Zoos Victoria To Save Reptile Once Thought Extinct

by | Oct 25, 2023
OK, it may not be as big—or as fire-breathing—as the dragons that swooped over Westeros on "Game of Thrones." But Australia's Victorian Grassland Earless Dragon is every bit as magical for simply hanging in there, decades after many thought it was extinct. Now Texas-based Colossal Biosciences is partnering to help preserve it—and sequence its genome.
MORE
Edge of Extinction: Pioneering Texas Biotech Colossal and BioRescue Race to Save the Northern White Rhino Species
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE
Meet the North Texas Cos. on the 2023 TIME100 Most Influential List
by | Jun 21, 2023
Featuring "a diverse group of businesses helping chart an essential path forward," the TIME100 Most Influential Companies list features five companies that are either headquartered in North Texas or have a strong presence here. See who they are—and what they're doing to disrupt the status quo and innovate for the future.
MORE
Google Cloud Launches AI-Powered Multiomics Suite, Taps Dallas-Based Colossal and Form Bio To Help Accelerate Life Science Research
by | May 19, 2023
Google Cloud has unveiled its AI-powered Multiomics Suite, which aims to accelerate the discovery and interpretation of genomic data, helping companies design precision treatments. As part of the rollout, Google Cloud noted that Dallas-based Colossal Biosciences has adopted the Multiomics Suite, and that Colossal spinout Form Bio has been selected to help other organizations adopt it. See what the new suite can do—and how it could help life get scienced.
MORE

SMU Is Bringing Its ‘Innovative Biotech Research’ to Pegasus Park

by | Oct 24, 2022
The Biotech+ Hub at Pegasus Park in Dallas has been attracting more and more life science startups and university teams. Now a whole herd of Mustangs are about to stampede there. The SMU Institute for Computational Biosciences at Pegasus Park will have space at the 23-acre development. SMU researchers from a variety of disciplines will be focusing on bio-scientific discoveries, leveraging advanced computational algorithms and technologies.

"We're excited to give SMU faculty this new opportunity to pursue world-changing research for good and to do so in close proximity to a broad range of academic, medical, corporate, and non-profit collaborators," says SMU Provost Elizabeth Loboa. "We're excited to give SMU faculty this new opportunity to pursue world-changing research for good and to do so in close proximity to a broad range of academic, medical, corporate, and non-profit collaborators," says SMU Provost Elizabeth Loboa.
MORE
acquired
Follow the Money: Medical Device Firm Orthofix Merges to Form Nearly $700M Revenue Business, Stealthy Men’s Health Startup Looks to Raise $2M, Dallas SPAC Targets $200M IPO, and More
by | Oct 17, 2022
In this week’s North Texas deal flow, you’ll also find news about Mavenir’s $155M raise, Pinnacle Realty Advisors raising $5M for ‘brokerage-as-a-service’ platform, Exela Technologies taking its European business unit public, American Airlines’ hydrogen fuel distribution investment, and more.
MORE
Mammoth Interest: The CIA Invests in Dallas-Based Colossal Biosciences
by | Oct 11, 2022
The Central Intelligence Agency has invested in Colossal through its nonprofit VC investment arm, In-Q-Tel, reports The Intercept. Named in honor of Q—the tech genius from the James Bond novels and movies—the VC firm was founded in 1999 to keep U.S. intelligence agencies on the cutting edge of "innovative and impactful technologies coming out of Silicon Valley and beyond." So why Colossal? "Strategically, it’s less about the mammoths and more about the capability," In-Q-Tel says.
MORE
The Last Word: Colossal’s Ben Lamm on Seeing His Startup Fuel a ‘Jeopardy’ Answer
by | Oct 3, 2022
In August, Colossal Biosciences announced it is working to "de-extinct" the Tasmanian tiger with the help of an Australian university and “marsupial biobanking.” It didn't take long for the TV show "Jeopardy" to notice—and work it into an answer.
MORE

See Inside: BioLabs Coworking Lab Opens at Pegasus Park for North Texas Life Science Startups

Dallas' status as a growing biotech center got a lift with the official opening of BioLabs, a new coworking space at the Biotech+ Hub at Pegasus Park. The 37,000-square-foot facility offers shared wet labs and office space for up to 35 life science startups.

BioLabs' goal: to serve as the epicenter for life science innovation in North Texas, and to empower biotech trailblazers pursing their next breakthrough.
MORE
Mammoth Project: Dallas’ Colossal Raises $60M to Advance Genetic Engineering and ‘De-Extinction’ Technologies
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid. With a total raise of $75 million to date, the startup aims to have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE
Dallas’ Ben Lamm and Harvard’s Dr. George Church Plan to ‘De-Extinct’ the Woolly Mammoth With Their Colossal New Startup
by | Sep 13, 2021
It's not "Jurassic Park," but it's almost as amazing. Hypergiant founder Ben Lamm is launching a new biosciences and genetics startup—Colossal—with $15 million in private funding. The goal: Use genomics to "de-extinct" the woolly mammoth and re-wild it on the Arctic tundra. Lamm's co-founder, Harvard geneticist Dr. George Church, says this "grand vision" could lead to big opportunities in conservation, biodiversity, carbon sequestration, and more.
MORE